Clinical characteristics, management and survival in young adults diagnosed with malignant melanoma: A population-based cohort study

被引:13
|
作者
Plym, Anna [1 ]
Ullenhag, Gustav J. [2 ]
Breivald, Mats [3 ]
Lambe, Mats [1 ,4 ]
Berglund, Anders [4 ,5 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden
[2] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden
[3] Orebro Univ Hosp, Orebro, Sweden
[4] Univ Uppsala Hosp, Reg Canc Ctr, Uppsala, Sweden
[5] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
关键词
CUTANEOUS MELANOMA; CANCER SURVIVAL; BIOPSY; EPIDEMIOLOGY; NETHERLANDS; ADOLESCENTS; EXCISION; SYSTEM; TRENDS; TIME;
D O I
10.3109/0284186X.2013.854928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Few studies to date have described the clinical features of malignant melanoma in young adulthood. Also, little is known about patterns of care in young patients. We examined and compared clinical characteristics, management and survival between young adult (15-39 years) and older adult melanoma patients in Central Sweden. Material and methods. Patients diagnosed with invasive malignant melanoma between 1997 and 2011 were identified in the Regional Quality Register of Cutaneous Malignant Melanoma in Central Sweden, a population-based register covering a source population of about two million. Data on clinical characteristics, management and survival were retrieved and compared according to age at diagnosis. Results. Of 5915 patients included in the study, 584 (9.9%) were between 15 and 39 years of age at diagnosis. Compared with older patients, young adult patients were more likely to be female, with higher proportions of thin, non-ulcerated melanomas, superficial spreading melanoma and melanomas located on the lower extremity. Young adults had shorter waiting times for surgical procedures and a higher proportion received surgical treatment according to guidelines. Overall, young patients had better relative survival than older patients. Age-related survival differences varied by stage of disease at diagnosis, and were most prominent in stage II disease. Conclusion. The observed differences in clinical characteristics, management and survival between young adult and older melanoma patients call for an improved understanding of not only disease etiology but also factors driving management decisions. A better understanding of these differences may help improve care and prognosis for melanoma patients of all ages.
引用
收藏
页码:688 / 696
页数:9
相关论文
共 50 条
  • [1] β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
    Lemeshow, Stanley
    Sorensen, Henrik Toft
    Phillips, Gary
    Yang, Eric V.
    Antonsen, Sussie
    Riis, Anders H.
    Lesinski, Gregory B.
    Jackson, Rebecca
    Glaser, Ronald
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (10) : 2273 - 2279
  • [2] CLINICAL AND HISTOPATHOLOGIC PREDICTORS OF SURVIVAL IN PATIENTS WITH MALIGNANT-MELANOMA - A POPULATION-BASED STUDY IN SWEDEN
    THORN, M
    PONTEN, F
    BERGSTROM, R
    SPAREN, P
    ADAMI, HO
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (10) : 761 - 769
  • [3] Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
    Naeser, Ylva
    Mikiver, Rasmus
    Ingvar, Christian
    Lambe, Mats
    Ullenhag, Gustav J.
    [J]. ECLINICALMEDICINE, 2023, 65
  • [4] Malignant pheochromocytoma in a population-based study -: survival and clinical results
    Wangberg, Bo
    Muth, Andreas
    Khorram-Manesh, Amir
    Jansson, Svante
    Nilsson, Ola
    Forssell-Aronsson, Eva
    Tisell, Larserik
    Ahlman, Hakan
    [J]. PHEOCHROMOCYTOMA, 2006, 1073 : 512 - 516
  • [5] Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis
    Morra, Simone
    Incesu, Reha-Baris
    Scheipner, Lukas
    Baudo, Andrea
    Jannello, Letizia Maria Ippolita
    de Angelis, Mario
    Siech, Carolin
    Goyal, Jordan A.
    Tian, Zhe
    Saad, Fred
    Califano, Gianluigi
    la Rocca, Roberto
    Capece, Marco
    Shariat, Shahrokh F.
    Ahyai, Sascha
    Carmignani, Luca
    de Cobelli, Ottavio
    Musi, Gennaro
    Tilki, Derya
    Briganti, Alberto
    Chun, Felix K. H.
    Longo, Nicola
    Karakiewicz, Pierre I.
    [J]. CANCERS, 2023, 15 (18)
  • [6] Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study
    Padrik, Peeter
    Valter, Ann
    Valter, Epp
    Baburin, Aleksei
    Innos, Kaire
    [J]. ACTA ONCOLOGICA, 2017, 56 (01) : 52 - 58
  • [7] Immunosuppressive Medications and Survival Outcomes in Patients with Melanoma: A Population-based Cohort Study
    Bogach, J.
    Wright, F.
    Cheng, S.
    Diong, C.
    Sutradhar, R.
    Baxter, N.
    Look-Hong, N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S142 - S142
  • [8] TRENDS IN TUMOR CHARACTERISTICS AND SURVIVAL OF MALIGNANT-MELANOMA, 1960-84 - A POPULATION-BASED STUDY IN SWEDEN
    THORN, M
    PONTEN, F
    BERGSTROM, R
    SPAREN, P
    ADAMI, HO
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (04) : 743 - 748
  • [9] Clinical and pathological characteristics of melanoma: a population-based study in a French regional population
    Barbe, C.
    Hibon, E.
    Vitry, F.
    Le Clainche, A.
    Grange, F.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (02) : 159 - 164
  • [10] Epidemiological characteristics of cutaneous malignant melanoma of the head and neck -: A population-based study
    Gillgren, P
    Månsson-Brahme, E
    Frisell, J
    Johansson, H
    Larsson, O
    Ringborg, U
    [J]. ACTA ONCOLOGICA, 1999, 38 (08) : 1069 - 1074